The Zhitong Finance App learned that recently, the clinical evidence-based smart “Yidu Zhixun” under Yidu Technology (02158.HK) collaborates with the nephrology professional platform “Kidney Health Knowledge Bank” to officially launch an evidence-based decision-making tool specific to nephrology. This is another important practice where Yidu Zhi followed the field of oncology and went deep into high-value specialties — Yidu Zhixun's specialization layout is being developed at an accelerated pace. Once the tool is launched, it can provide nephrologists with second-level response and clinical evidence-based support with traceable sources of evidence. It will also use specialized knowledge to feed back the development of new drugs and real-world research in the field of nephrology.

The Zhitong Finance App learned that recently, the clinical evidence-based smart “Yidu Zhixun” under Yidu Technology (02158.HK) collaborates with the nephrology professional platform “Kidney Health Knowledge Bank” to officially launch an evidence-based decision-making tool specific to nephrology. This is another important practice where Yidu Zhi followed the field of oncology and went deep into high-value specialties — Yidu Zhixun's specialization layout is being developed at an accelerated pace. Once the tool is launched, it can provide nephrologists with second-level response and clinical evidence-based support with traceable sources of evidence. It will also use specialized knowledge to feed back the development of new drugs and real-world research in the field of nephrology.